or Try an Advanced Search...

    Technical Analysis for MIST - Milestone Pharmaceuticals Inc.

    Grade Last Price % Change Price Change
    D 1.74 -0.57% -0.01
    MIST closed down 0.57 percent on Friday, May 17, 2024, on 1.3 times normal volume.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Up Up
    Historical MIST trend table...
    Date Alert Name Type % Chg
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Bollinger Band Squeeze Range Contraction -0.57%
    Up 3 Days in a Row Strength -0.57%
    Bollinger Band Squeeze Range Contraction 0.58%
    Gapped Up Strength 0.58%
    Bollinger Band Squeeze Range Contraction 1.16%
    Narrow Range Bar Range Contraction 1.16%
    Gapped Up Strength 1.16%
    Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.35%
    Older End-of-Day Signals for MIST ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Support 1 day ago
    2x Volume Pace 1 day ago
    1.5x Volume Pace 1 day ago
    Down 2 % 1 day ago
    Down 1% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    MIST Chart by TradingView
    Basic chart:

    Profile

    Milestone Pharmaceuticals Inc., a biopharmaceutical company, develops and commercializes drugs for the treatment of cardiovascular indications. It offers Etripamil that completed Phase 2 clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada, as well as for treating Atrial Fibrillation and Angina. The company was founded in 2003 and is headquartered in Montréal, Canada.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cardiology Cardiac Arrhythmia Atrial Fibrillation Angina Circulatory System Cardiovascular System Tachycardia Ventricular Tachycardia

    Is MIST a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 13 Milestone Pharmaceuticals GAAP EPS of -$0.21 beats by $0.05
    May 13 Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
    May 2 Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024
    Apr 3 Milestone® Pharmaceuticals to Present at the 23rd Annual Needham Healthcare Conference
    Apr 1 Milestone® Pharmaceuticals to Present Data on Etripamil at the American College of Cardiology and European Heart Rhythm Association Annual Conferences
    Mar 21 Milestone Pharmaceuticals reports Q4 results
    Feb 29 Milestone® Pharmaceuticals to Participate in a Corporate Panel Discussion at TD Cowen 44th Annual Health Care Conference
    Feb 29 Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Feb 29 Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants
    Feb 26 Milestone Pharmaceuticals Announces Plan to Resubmit NDA for Etripamil for the Treatment of PSVT
    See more MIST news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 4.39
    52 Week Low 1.35
    Average Volume 194,699
    200-Day Moving Average 2.26
    50-Day Moving Average 1.67
    20-Day Moving Average 1.67
    10-Day Moving Average 1.72
    Average True Range 0.09
    RSI (14) 55.75
    ADX 18.76
    +DI 16.35
    -DI 10.36
    Chandelier Exit (Long, 3 ATRs) 1.55
    Chandelier Exit (Short, 3 ATRs) 1.77
    Upper Bollinger Bands 1.80
    Lower Bollinger Band 1.55
    Percent B (%b) 0.77
    BandWidth 14.60
    MACD Line 0.02
    MACD Signal Line 0.01
    MACD Histogram 0.0087
    Fundamentals Value
    Market Cap 58.26 Million
    Num Shares 33.5 Million
    EPS -1.38
    Price-to-Earnings (P/E) Ratio -1.26
    Price-to-Sales 12.28
    Price-to-Book 1.87
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.80
    Resistance 3 (R3) 1.80 1.77 1.79
    Resistance 2 (R2) 1.77 1.76 1.78 1.79
    Resistance 1 (R1) 1.76 1.75 1.75 1.76 1.78
    Pivot Point 1.73 1.73 1.73 1.74 1.73
    Support 1 (S1) 1.72 1.72 1.71 1.72 1.70
    Support 2 (S2) 1.69 1.71 1.70 1.69
    Support 3 (S3) 1.68 1.69 1.69
    Support 4 (S4) 1.68